Quantum leap in the reliability of mass spectrometry-based proteomics
Modern mass spectrometry systems enable scientists to routinely determine the quantitative composition of cells or tissue samples. However, different analysis software packages often produce different results from the same raw data. An international team of researchers led by Professor Stefan Tenzer from the Mainz University Medical Center has now addressed this problem.
In the framework of an international collaboration with leading laboratories worldwide, the team has compared and modified various analysis software packages to ensure that the different software solutions produce consistent results. A wide range of laboratories around the world are benefiting from this work, which enables researchers to analyze or compare the results of quantitative proteomics assays in a standardized way. This is crucial to detect certain organic diseases, such as cancer, at an early stage. The results of Tenzer and his team have now been published in the highly respected academic journal, Nature Biotechnology.
When doctors want to find the cause of a particular illness, they have to take samples of cells or bodily fluids. These samples are then analyzed by modern Omics techniques which enable to reproducibly quantify thousands of proteins across large numbers of samples to identify novel biomarkers for diseases. The analysis of these highly complex datasets critically depends on specialized software packages. Unfortunately, different software packages sometimes deliver divergent results from the same raw data, thus complicating the analysis.
This is exactly the problem that Professor Stefan Tenzer and his team from the Institute of Immunology at the University Medical Center of Johannes Gutenberg University Mainz (JGU) set out to resolve. "We wanted to find a way of optimally comparing samples, even when different analysis software sometimes produces deviating results," explained Tenzer. For his latest project he used two defined samples with precisely defined ratios of constituents.
The bioinformatics specialists in Tenzer's team, Dr. Pedro Navarro and Dr. Jörg Kuharev, developed a specialist piece of software, termed LFQbench. This allowed the team to study the differences between the various analysis programs in detail. "Using LFQbench, we were able to show that the results delivered by the various programs differed significantly," explained Navarro. "This finding alone has significant impact for the scientific community.
But we have taken the project a step further: Our close collaboration with the developers of the individual programs enabled them to modify and improve their analysis packages so that they now produce highly convergent results," added Tenzer. This broadens the scope of applications of the mass spectrometry technique known as quantitative proteomics. A proteome is the entirety of proteins expressed by a cell. "This means that in the future, mass spectrometry will be able to provide even more benefits both in basic research and as a potential diagnostic tool," Tenzer pointed out.
"This development represents a breakthrough for mass spectrometry-based quantitative proteomics and makes this method increasingly important as a standard procedure for use in the diagnosis of various disorders, such as cancer or allergies," emphasized the Chief Scientific Officer of the Mainz University Medical Center, Professor Ulrich Förstermann. "I am particularly proud that our researchers are delivering applied research with such significant impact."
The pioneering results were achieved under the aegis of the technology platform "Mass Spectrometry and Quantitative Proteomics" based at the Research Center for Immunotherapy (FZI) at Johannes Gutenberg University Mainz (JGU). "This success demonstrates the necessity of combining different areas of expertise in technology platforms at the University Medical Center. Without central support, it is nowadays almost impossible to accomplish achievements of this kind," said Professor Hansjörg Schild, Director of the Institute of Immunology and coordinator of the FZI for many years.
Over recent years, Professor Stefan Tenzer and his team in Mainz have developed several improvements to the techniques used for mass spectrometry-based quantitative proteomics. These methods reproducibly detect and quantify thousands of proteins in samples of cells, tissues, or bodily fluids, and enable researchers to identify proteins that are differentially expressed. "The years of work within the technology platform, especially in international joint projects, have paid off in terms of this quantum leap forward in mass spectrometry-based quantitative proteomics," concluded Tenzer.
"A multicenter study benchmarks software tools for label-free proteome quantification"
Pedro Navarro1,11, Jörg Kuharev1,11, Ludovic C Gillet2, Oliver M. Bernhardt3, Brendan MacLean4, Hannes L. Röst2, Stephen A. Tate5, Chih-Chiang Tsou6, Lukas Reiter3, Ute Distler1, George Rosenberger2,7, Yasset Perez-Riverol8, Alexey I. Nesvizhskii6,9, Ruedi Aebersold2,10, Stefan Tenzer1
1 Institute of Immunology, University Medical Center of Johannes Gutenberg University Mainz, Mainz, Germany
2 Department of Biology, Institute of Molecular Systems Biology, Eidgenoessische Technische Hochschule (IMSB-ETH) Zurich, Zurich, Switzerland
3 Biognosys AG, Schlieren, Switzerland
4 Department of Genome Sciences, University of Washington, Seattle, Washington, USA
5 AB Sciex, Concord, Ontario, Canada
6 Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA
7 PhD Program in Systems Biology, University of Zurich and Eidgenoessische Technische Hochschule (ETH) Zurich, Zurich, Switzerland
8 European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK
9 Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA
10 Faculty of Science, University of Zurich, Zurich, Switzerland
11 These authors contributed equally to this work.
Professor Stefan Tenzer
Head of the Core Facility for Mass Spectrometry
Institute of Immunology
Mainz University Medical Center
Oliver Kreft, Press and Public Relations, Mainz University Medical Center
phone +49 6131 17-7424, fax +49 6131 17-3496, e-mail: email@example.com
Petra Giegerich | idw - Informationsdienst Wissenschaft
Molecular evolution: How the building blocks of life may form in space
26.04.2018 | American Institute of Physics
Multifunctional bacterial microswimmer able to deliver cargo and destroy itself
26.04.2018 | Max-Planck-Institut für Intelligente Systeme
Magnetic resonance imaging, or MRI, is a widely used medical tool for taking pictures of the insides of our body. One way to make MRI scans easier to read is...
At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.
Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...
Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.
Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
26.04.2018 | Power and Electrical Engineering
26.04.2018 | Life Sciences
26.04.2018 | Power and Electrical Engineering